Skip to main content
. 2020 Feb 26;11(4):956–963. doi: 10.1111/1759-7714.13348

Figure 2.

Figure 2

FOXO3 is downregulated in breast cancer and correlated with the prognosis. (a) Low FOXO3 expression in breast cancer compared with the normal group. (b) Low FOXO3 expression was lower in breast cancer based on individual cancer stages. (c) Relationship between FOXO3 (204131_s_at probe) expression level and overall survival of patients with breast cancer. (d) Relationship between FOXO3 (204131_s_at probe) expression level and relapse‐free survival of patients with breast cancer.